Capillary Technologies India IPO Details

MAINBOARD

Capillary Technologies India IPO opens for subscription on 14 Nov 2025 and closes on 18 Nov 2025. The IPO will be listed on NSE, BSE with the tentative listing date set for 21 Nov 2025.

Capillary Technologies India IPO price band has been fixed at ₹549 – ₹577 per share.The face value is ₹2 per share with a lot size of 25.

Capillary Technologies India IPO total issue size comprises 1,52,07,998 shares (aggregating up to ₹877.50 Cr.). This includes a fresh issue of 59,79,202 shares (aggregating up to ₹345.00 Cr.). Offer for Sale consists of 92,28,796 shares (aggregating up to ₹532.50 Cr.). Pre-issue shareholding stands at 7,33,29,138, which will increase to 7,93,08,340 post-issue.

Capillary Technologies India IPO carries a ₹55 (9.5%) GMP, reflecting investor sentiment.

Capillary Technologies India IPO Lot Size : Retain Minimum is 1 lot (25 shares) amounting to ₹14,425. Retain Maximum is 13 lots (325 shares) amounting to ₹187,525. SHNI Minimum is 14 lots (350 shares) amounting to ₹201,950. SHNI Maximum is 69 lots (1,725 shares) amounting to ₹995,325. BHNI Minimum is 70 lots (1,750 shares) amounting to ₹1,009,750.

The Lead Managers for Capillary Technologies India IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Jm Financial Limited, IIFL Capital Services Limited, Nomura Financial Advisory And Securities (India) Pvt Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.

For detailed information, Refer to the Capillary Technologies India Limited RHP.

Capillary Technologies India IPO Details

Listing Price : ₹571.9 at a Discount of 0.88%
Open Date
14 Nov 2025
Close Date
18 Nov 2025
Listing Date
21 Nov 2025
Issue Price
₹549 - ₹577
Face Value
₹2 per share
Lot Size
25
GMP
₹55 (9.5%)
Issue Type
IPO
Listing On
NSE, BSE
Type
Book Built Issue
Share holding pre issue
73329138
Share holding post issue
79308340
Total Issue Size
1,52,07,998 shares (aggregating up to ₹877.50 Cr.)
Fresh Issue
59,79,202 shares (aggregating up to ₹345.00 Cr.)
Offer for Sale
92,28,796 shares (aggregating up to ₹532.50 Cr.)

Capillary Technologies India IPO Subscription

Capillary Technologies India IPO Application Wise Breakup (Approx)

Capillary Technologies India IPO Dates

  • 14 Nov 2025
    Opening dateOPD
  • 18 Nov 2025
    Closing dateCOD
  • 19 Nov 2025
    Allotment Date BOA
  • 20 Nov 2025
    Initiation of RefundsIOR
  • 20 Nov 2025
    Credit of SharesCOS
  • 21 Nov 2025
    Listing dateLID

Capillary Technologies India IPO Lot Size

ApplicationLotsSharesAmount
Retain Minimum125₹14,425
Retain Maximum13325₹187,525
SHNI Minimum14350₹201,950
SHNI Maximum691725₹995,325
BHNI Minimum701750₹1,009,750

Capillary Technologies India IPO Reservation

Promoter Holding

Pre Issue:67.94%
Post Issue:52.05%
Promoter Names:
Capillary Technologies International Pte Ltd, Aneesh Reddy Boddu

Capillary Technologies India IPO Valuations

ROCE:2.76%
DEBT/EQUITY:0.18
RONW:2.85%
PAT MARGIN:2.37%
PRICE TO BOOK VALUE:8.87
P/E Pre IPO:298.93
P/E Post IPO:2214.95

Capillary Technologies India Financial Information

Period Ended30 Sep 202531 Mar 202531 Mar 202431 Mar 2023
Assets892.33838.65871.07466.41
Total Income362.56611.87535.44266.25
Profit After Tax1.0314.15-68.35-88.56
EBITDA39.8278.57-1.49-58.34
NET Worth509.38481.42452.1399.75
Reserves and Surplus149.34170.2630.8931.99
Total Borrowing88.94100.0977.17147.47
Amount in ₹ Crore

About Capillary Technologies India IPO

Capillary Technologies India Ltd is a leading Indian software-as-a-service (SaaS) company that specializes in customer loyalty and engagement solutions. Founded in 2008 and headquartered in Bengaluru, Capillary offers a comprehensive suite of products that help brands understand and engage their customers more effectively through data-driven insights.

Key Offerings:

  • Loyalty Management Solutions: Capillary provides scalable, customizable loyalty programs for enterprises across industries like retail, FMCG, and hospitality.
  • Customer Engagement & Marketing Automation: The platform enables personalized marketing through SMS, email, push notifications, and more.
  • AI & Analytics: Their tools leverage AI and machine learning to deliver real-time customer insights and predictive analytics.
  • Omnichannel CRM: Helps brands maintain consistent engagement with customers across online and offline channels.
  • Clients & Global Reach: Capillary serves over 250 brands across more than 30 countries, including major names like Tata, Domino’s, Jockey, PUMA, and Shell.

The company primarily operates on a subscription-based SaaS model, generating revenue from software licenses, professional services, and support.

Strength Of Capillary Technologies India IPO

  • Trusted Partner in Loyalty Solutions.
  • Comprehensive Solutions and Scalable Cloud-Based Infrastructure with Seamless Integration for Diverse Segments.
  • Diverse Long-Term Customer Relationships with High Net Revenue Retention.
  • Diverse Long-Term Customer Relationships with High Net Revenue Retention.
  • Experienced Leadership Team backed by Marquee Investor Base.

Risk Of Capillary Technologies India IPO

  • Our Company, certain of our Subsidiaries, and our Directors are involved in outstanding legal proceedings. Any adverse outcome in such proceedings may have an adverse impact on our reputation, business, financial condition, results of operations and cash flows.
  • We changed our business model for campaign services in Fiscal 2025. Accordingly, there are certain differences in the manner in which revenue from campaign services has been recognized in the Restated Consolidated Statement of Profit and Loss for Fiscal 2024 and Fiscal 2023 as compared to six-month period ended September 30, 2025 and Fiscal 2025.
  • If we fail to integrate our offerings with a variety of operating systems, software applications and hardware that are developed by others, our service may become less marketable and less competitive or obsolete, and our operating results would be harmed.
  • Our reliance on borrowings to fund our working capital requirements has increased during the six-month period ended September 30, 2025 and the last three Fiscals and any inability to refinance or repay such borrowings in a timely manner could adversely affect our business, results of operations, financial condition and cash flows.
  • We propose to utilise Rs. 1,430 million from the Net Proceeds towards funding our cloud infrastructure cost. We have entered into certain arrangements with technology service providers and have made certain annual spend commitments which are higher than the amount proposed to be utilised from the Net Proceeds towards funding our cloud infrastructure cost. Any inability to incur such expenditures in full will strain our resources and, may result in variations in the deployment of Net Proceeds.
  • There have been certain instances of delays in payment of statutory dues by our Company in the past. Any delay in payment of statutory dues by our Company in future, may result in the imposition of penalties and in turn may have an adverse effect on our business, financial condition, results of operation and cash flows.
  • The financial information of certain of our foreign Subsidiaries, which are not material, included in the Restated Consolidated Financial Information have not been audited and are based on management information, due to which our consolidated financial statements and investor confidence may be adversely affected.
  • We have witnessed delays in repayment of loans/borrowings in the past for which our Statutory Auditors have included certain remarks in the Companies (Auditor's Report) Order, 2020, for the years ended March 31, 2024 and March 31, 2023. We cannot assure you that any similar or other matters prescribed under the Companies (Auditor's Report) Order, 2020, will not form part of our financial statements for the future fiscal periods, which could have an adverse effect on our reputation, the trading price of the Equity Shares, results of operations, cash flows and financial condition.
  • Our corporate Promoter issued share warrants to one of our customers as part of our revenue contract. The cost of issuing such warrants are recognized in our books of accounts and may continue to impact our revenue, profitability and assets until the entire cost of such warrant issuance is amortised.
  • An inability to maintain adequate insurance cover in connection with our business may adversely affect our operations and profitability.

Objectives Capillary Technologies India IPO

1. Funding our cloud infrastructure cost

2. Investment in research, designing and development of our products and platform

3. Investment in purchase of computer systems for our business

4. Funding inorganic growth through unidentified acquisitions and general corporate purposes

Company Contact Details

Capillary Technologies India Ltd
#360 bearing PID No 101, 360,
15th Cross Rd, Sector 4,
HSR Layout, Bengaluru, Karnataka
Bengaluru, Karnataka, 560102
Phone: +91 80 4122 5179
Email: investorrelations@capillarytech.com
Website: http://www.capillarytech.com/

Registrar Contact Details

Name: MUFG Intime India Private Limited
Phone: +91-22-4918 6270

Comments